Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron Obtains $209M Revolving Credit Facility

NEW YORK, July 8 (GenomeWeb News) - Thermo Electron has obtained a revolving €175 million ($209 million) credit facility, the company said in an SEC filing yesterday.

 

The five-year facility, sealed on June 30, was made with ABN AMRO Bank, Barclays Bank, Bank of Tokyo-Mitsubishi Trust Company, JPMorgan ChaseBank, Banca Intesa, Bank Austria Creditanstalt, BNP Paribas, and Key Bank, Thermo said in the filing.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.